Raymond James Financial Inc. Makes New $124,000 Investment in Enhabit, Inc. (NYSE:EHAB)

Raymond James Financial Inc. bought a new stake in Enhabit, Inc. (NYSE:EHAB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 15,836 shares of the company’s stock, valued at approximately $124,000.

Other institutional investors and hedge funds have also modified their holdings of the company. FMR LLC boosted its position in shares of Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after buying an additional 1,967 shares during the period. Jane Street Group LLC increased its position in shares of Enhabit by 514.3% in the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after purchasing an additional 754,395 shares during the last quarter. XTX Topco Ltd acquired a new stake in shares of Enhabit during the 3rd quarter valued at approximately $123,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Enhabit in the 3rd quarter valued at about $450,000. Finally, Geode Capital Management LLC boosted its position in Enhabit by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock valued at $8,987,000 after purchasing an additional 10,538 shares during the period.

Enhabit Stock Performance

EHAB opened at $7.74 on Friday. Enhabit, Inc. has a fifty-two week low of $6.85 and a fifty-two week high of $10.84. The business has a fifty day simple moving average of $8.49 and a 200-day simple moving average of $8.00. The firm has a market cap of $390.46 million, a PE ratio of -3.33 and a beta of 1.60. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Wall Street Analysts Forecast Growth

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research report on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.